{
  "documentMetadata": {
    "title": "Lyme Disease, Meningitis, Encephalitis",
    "sourceFile": "Lyme_disease/Lyme Disease, Meningitis, Encephalitis.pdf"
  },
  "content": [
    {
      "type": "header",
      "level": 1,
      "text": "Clinical Setting"
    },
    {
      "type": "paragraph",
      "text": "Encephalitis or meningitis can be an early or late manifestations of Lyme Disease; Early disease typically presents as meningitis, cranial neuritis, radiculoneuritis, and more rarelyencephalomyelitis, and has a more rapid onset of illness. Later onset neuroborrelia disease can involve peripheral or central nervous system and the onset is more insidious."
    },
    {
      "type": "nestedContent",
      "content": [
        {
          "type": "header",
          "level": 2,
          "text": "Variable clinical syndromes:"
        },
        {
          "type": "list",
          "items": [
            "Cranial nerve palsy; most often 7th cranial nerve",
            "Headache and neck pain with CSF picture consistent with a lymphocytic aseptic meningitis",
            "Cognitive impairment: poor memory, depression, somnolence",
            "May have other associated late-stage manifestations: carditis or arthritis; usually early in course; maybe isolated finding"
          ]
        }
      ]
    },
    {
      "type": "crossReference",
      "referenceData": {
        "text": "For details on diagnostic methods see: Lyme Disease, Diagnosis.",
        "targetType": "internalDocument",
        "targetIdentifier": "Lyme Disease, Diagnosis"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Etiologies"
    },
    {
      "type": "list",
      "items": [
        "Borrelia burgdorferi"
      ]
    },
    {
      "type": "header",
      "level": 1,
      "text": "Primary Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Hospitalized"
        },
        "components": [
          {
            "drug": "Ceftriaxone",
            "dose": "2 gm IV q24h (adult) or 50-75 mg/kg IV q24h (child)"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Ambulatory"
        },
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "100 mg po bid or 200 mg po once daily"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        },
        "notes": "(use only if no spinal or parenchymal brain involvement; in those settings, IV therapy is warranted)"
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "appliesTo": {
          "description": "Pediatric dose ambulatory"
        },
        "components": [
          {
            "drug": "Doxycycline",
            "dose": "4.4 mg/kg/day po divided bid (max.dose 100 mg bid)"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        }
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Alternative Regimens"
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Penicillin G",
            "dose": "5 million units IV q6h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        }
      }
    },
    {
      "type": "drugRegimen",
      "regimenData": {
        "intent": "treatment",
        "components": [
          {
            "drug": "Cefotaxime",
            "dose": "2 gm IV q8h"
          }
        ],
        "durationDetail": {
          "fixedDuration": "14 days"
        },
        "notes": "(where available)"
      }
    },
    {
      "type": "header",
      "level": 1,
      "text": "Antimicrobial Stewardship"
    },
    {
      "type": "paragraph",
      "text": "Pediatrics: Doxycycline can be safely administered for up to 21 days regardless of age (AAP Red Book 2018, Section 4; J Pediatr 166:1246, 2015)."
    },
    {
      "type": "header",
      "level": 1,
      "text": "Comments"
    },
    {
      "type": "list",
      "items": [
        "IV therapy risks: line infection or thrombosis; pseudolithiasis from crystals of ceftriaxone.",
        "See also, Post-Lyme Disease Syndrome.",
        "2020 Clinical practice guidelines (Neurology 96:262, 2021) and (Clin Infect Dis 72: e1-e48, 2020)",
        "Review in JAMA 315:1767, 2016."
      ]
    }
  ]
}
